University of Glasgow

University of Glasgow

Signal active

Investment Firm

Overview

Founded in 1451, the University of Glasgow is the fourth oldest university in the English-speaking world. Today we are in the top 1% of the world's universities.

Glasgow’s college system enables interdisciplinary collaboration while fostering a sense of belonging. We have four colleges, each bringing together the research and teaching expertise of a number of schools and institutes. Every college also has a graduate school.

The University is expanding and evolving. Following the closure of the Western Infirmary site in 2015, we plan to invest £80m in new buildings and equipment and £55m on refurbishing facilities over the next five years.

Highlights

Founded

1451

Industry

Education

Employees

10001+

Investment

3

Lead Investment

1

Exits

undefined

Stages

Early Stage Venture, Seed

Investor Type

University Program

Location

Europe

Contact Information

Social

Profile Resume

University of Glasgow, established in 1451 and headquartered in Europe., specializes in Early Stage Venture, Seed investments across Biotechnology, Pharmaceutical, Financial Services, Finance, Banking, Venture Capital, Angel Investment, Life Science, Incubators, Health Care. Their recent investments include Clyde Biosciences, Scottish Investment Bank, Epidarex Capital, Zinc, Neuranics. The highest investment round they participated in was $297.5M. Among their most notable exits are Clyde Biosciences and Scottish Investment Bank. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Arthur Smith

Arthur Smith

Director of Operations, James Watt Nano-fabrication Centre

imagePlace Esther K. Papies

Esther K. Papies

Researcher in Behaviour Change

imagePlace Justin Sperling

Justin Sperling

Postdoctoral Research Associate

imagePlace Ravinder Dahiya

Ravinder Dahiya

Professor of Electronics and Nanoengineering

imagePlace Vihar Georgiev

Vihar Georgiev

Senior Lecturer (Associate Professor) & Deputy Group Leader of Device Modelling Group

imagePlace Jeremy Singer

Jeremy Singer

Senior Lecturer

Investment portfolio

University of Glasgow has made 3 investments. Their most recent investment was on Sep 27, 2023, when Neuranics raised $2.3M.

investments

3

Diversity investments

0

Lead investments

1

Number of exits

undefined

Investments

3

Annouced DateOrganization NameIndustryMoney Raised
Apr 13, 2015
Clyde Biosciences Clyde Biosciences
Biotechnology2.9M
Sep 27, 2023
Neuranics Neuranics
Health Care2.3M
Apr 10, 2024
Clyde Hydrogen Systems Clyde Hydrogen Systems
-1.3M

Exits

0

Funding Timeline

Funding rounds

3

Investors

3

Funds

0

Funding Rounds

3

University of Glasgow has raised 3 rounds. Their latest funding was raised on Apr 10, 2024 from a Pre Seed Round - Clyde Hydrogen Systems round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Apr 13, 2015
Series A - Clyde Biosciences Series A - Clyde Biosciences
-2.9M-
Sep 27, 2023
Pre Seed Round - Neuranics Pre Seed Round - Neuranics
-2.3M-
Apr 10, 2024
Pre Seed Round - Clyde Hydrogen Systems Pre Seed Round - Clyde Hydrogen Systems
-1.3M-

Investors

4

University of Glasgow is funded by 4 investor(s). Engineering and Physical Sciences Research Council and Local Policy Innovation Partnership Kantor are the most recent investors.

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.